A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Nuclear Magnetic Resonance Core Bookmark and Share

Nuclear Magnetic Resonance Core

The main focus of the facility is to apply high resolution Nuclear Magnetic Resonance (NMR) spectroscopy to structural characterization of biomolecules, small organic compounds and natural products; to investigate interactions between biomolecules, biomolecules and ligands, to do the NMR-based metabolomics and fragment-based drug screening etc.
 
The facility has commercial software such as Discover Studio, Chenomx as well as some free software for biomolecular characterization and metabolomics studies.
 

Abstract

The Nuclear Magnetic Resonance (NMR) Core is located in the Hilton Building, Room 123. The main focus of this core is to apply high resolution NMR spectroscopy to the structural characterization of biomolecules, small organic compounds, natural products; investigation of biomolecular complexes including protein-protein, protein-nucleic acid and protein-ligand complexes; identification of metabolites in biofluids; and fragment-based drug screening.
 

The Nuclear Magnetic Resonance Core has one Bruker 600 MHz Avance NMR instrument that is equipped with four channels, a TXI cryo-probe and a room temperature probe, and one Bruker 700 MHz Ascend equipped with TCI cryoprobe and a sample jet can handle up to 480 NMR tubes for batch screening study. Both instruments are operated with HP workstations running the Linux operating system, have pulse shaping capability on three channels (1H/13C/15N), and 2H decoupling capability.
 

Pricing

Prices and availability vary. Please Contact Us or login to the core  iLab site for current information.
 
To schedule instrument time or set up a consultation please visit the core iLab Site
 

Services and Equipment

Services
 
  1. Understand the mechanism of actions of proteins and nucleic acids at atomic details through the characterization of structures and interaction of the biomolecules
  2. Analysis of protein-ligand interactions and fragment-based drug screening
  3. Structure elucidation of natural products and synthetic compounds
  4. Metabolomics
 
Equipment
 
600 MHz Bruker Avance NMR Instrument
Bruker 600 MHz Avance equipped with a TXI cryoprobe and a sample case holds up to 24 samples.
   
700 MHz NMR Instrument
Bruker 700 MHz Ascend equipped with TCI cryoprobe and a sample jet can handle up to 480 NMR tubes for batch screening study.

 
Both instruments are operated with HP workstations running the Linux operating system, have pulse shaping capability on three channels (1H/13C/15N), and 2H decoupling capability.
 
NMR Core also hosts an Isothermal titration calorimeter.

Nuclear Magnetic Resonance Team

Nuclear Magnetic Resonance Core

Nuclear Magnetic Resonance Core

The main focus of the facility is to apply high resolution Nuclear Magnetic Resonance (NMR) spectroscopy to structural characterization of biomolecules, small organic compounds and natural products; to investigate interactions between biomolecules, biomolecules and ligands, to do the NMR-based metabolomics and fragment-based drug screening etc.
 
The facility has commercial software such as Discover Studio, Chenomx as well as some free software for biomolecular characterization and metabolomics studies.
 

Abstract

Abstract

The Nuclear Magnetic Resonance (NMR) Core is located in the Hilton Building, Room 123. The main focus of this core is to apply high resolution NMR spectroscopy to the structural characterization of biomolecules, small organic compounds, natural products; investigation of biomolecular complexes including protein-protein, protein-nucleic acid and protein-ligand complexes; identification of metabolites in biofluids; and fragment-based drug screening.
 

The Nuclear Magnetic Resonance Core has one Bruker 600 MHz Avance NMR instrument that is equipped with four channels, a TXI cryo-probe and a room temperature probe, and one Bruker 700 MHz Ascend equipped with TCI cryoprobe and a sample jet can handle up to 480 NMR tubes for batch screening study. Both instruments are operated with HP workstations running the Linux operating system, have pulse shaping capability on three channels (1H/13C/15N), and 2H decoupling capability.
 

Pricing

Pricing

Prices and availability vary. Please Contact Us or login to the core  iLab site for current information.
 
To schedule instrument time or set up a consultation please visit the core iLab Site
 

Services and Equipment

Services and Equipment

Services
 
  1. Understand the mechanism of actions of proteins and nucleic acids at atomic details through the characterization of structures and interaction of the biomolecules
  2. Analysis of protein-ligand interactions and fragment-based drug screening
  3. Structure elucidation of natural products and synthetic compounds
  4. Metabolomics
 
Equipment
 
600 MHz Bruker Avance NMR Instrument
Bruker 600 MHz Avance equipped with a TXI cryoprobe and a sample case holds up to 24 samples.
   
700 MHz NMR Instrument
Bruker 700 MHz Ascend equipped with TCI cryoprobe and a sample jet can handle up to 480 NMR tubes for batch screening study.

 
Both instruments are operated with HP workstations running the Linux operating system, have pulse shaping capability on three channels (1H/13C/15N), and 2H decoupling capability.
 
NMR Core also hosts an Isothermal titration calorimeter.

Team

Nuclear Magnetic Resonance Team

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Recognized nationwide for its innovative biomedical research, City of Hope's Beckman Research Institute is home to some of the most tenacious and creative minds in science.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
Media Inquiries/Social Media

For media inquiries contact:

Dominique Grignetti
800-888-5323
dgrignetti@coh.org

 

For sponsorships inquiries please contact:

Stefanie Sprester
213-241-7160
ssprester@coh.org

Christine Nassr
213-241-7112
cnassr@coh.org

 
CONNECT WITH US
Facebook  Twitter  YouTube  Blog
 
NEWS & UPDATES
  • Beyond the pink ribbons, special product fundraisers, and the pastel sea of color that marks October, Breast Cancer Awareness Month offers a reason to celebrate and to reflect. More than 2.8 million breast cancer survivors live in the U.S. They are survivors of the second most-common cancer in women, behind ski...
  • Gliomas, a type of tumor that grows in the brain, are very difficult to treat successfully due to their complex nature. That might not always be the case. First some background: The most aggressive and common type of primary brain tumor in adults is glioblastoma. Although the brain tumor mass can often be remov...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. The result is rashes and, sometimes, tumors, which can be mistaken for other dermatological conditions. In a smal...
  • Weighing your breast cancer risk? One study suggests a measure to consider is skirt size. A British study suggests that for each increase in skirt size every 10 years after age 25, the five-year risk of developing breast cancer postmenopause increases from one in 61 to one in 51 – a 77 percent increase in risk....
  • Runners prize medals for 5Ks and marathons. Becky Stokes has a medal she cherishes from a very different kind of race: the marathon of treatments necessary to beat her aggressive triple-negative breast cancer. Just a week ago, she completed her last radiation treatment, and danced in the hospital with the staff...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free. Darakjian’s s...
  • The environment plays a role in causing cancer – this much we know. But scientists are still trying to understand what that role is, what environmental factors are in play and how precisely those factors are linked to cancer. Now City of Hope researchers have unlocked a clue as to how one carcinogen triggers ca...
  • Jonathan Yamzon, M.D., assistant clinical professor of surgery in the Division of Urology and Urologic Oncology, explains his approach to what’s known as “active surveillance” of men with prostate cancer. Patients need to be educated about their treatment options, he writes. Active surveillanc...
  • For most prostate cancer patients, surgery or radiation therapy is the initial and primary treatment against the disease. But some patients can benefit from chemotherapy and hormone therapy too, especially if there are signs of a relapse or if the cancer has spread beyond the prostate gland. Here, Cy Stein, M.D...
  • Cancer research has yielded scientific breakthroughs that offer patients more options, more hope for survival and a higher quality of life than ever before. The 14.5 million cancer patients living in the United States are living proof that cancer research saves lives. Now, in addition to the clinic, hospital an...
  • Advances in cancer treatment, built on discoveries made in the laboratory then brought to the bedside, have phenomenally changed the reality of living with a cancer diagnosis. More than any other time in history, people diagnosed with cancer are more likely to survive and to enjoy a high quality of life. Howeve...
  • While health care reform has led to an increase in the number of people signing up for health insurance, many people remain uninsured or are not taking full advantage of the health benefits they now have. Still others are finding that, although their premiums are affordable, they aren’t able to see the do...
  • Kidney cancer rates and thyroid cancer rates in adults have continued to rise year after year. Now a new study has found that incidence rates for these cancers are also increasing in children — particularly in African-American children. The study, published online this month in Pediatrics, examined childhood ca...
  • Thyroid cancer has become one of the fastest-growing cancers in the United States for both men and women. The chance of being diagnosed with the cancer has nearly doubled since 1990. This year an estimated 63,000 people will be diagnosed with thyroid cancer in the United States and nearly 1,900 people will die ...
  • Older teenagers and young adults traditionally face worse outcomes than younger children when diagnosed with brain cancer and other central nervous system tumors. A first-of-its-kind study shows why. A team of researchers from the departments of Population Sciences and Pathology at City of Hope recently examine...